Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Số 68 (2014) TIM MẠCH DỰ PHÒNG

No translate

Published: October 31, 2014
Views: 674

Abstract

Background: Carotid intima media thickness (CIMT) is a surrogate marker for atherosclerosis, used to identify asymptomatic individuals at increased risk of cardiovascular events. The primary objective of this study was to obtain the distribution of CIMT measurements in Asian individuals with cardiovascular disease (CVD) risk factors who were not receiving lipid-lowering agents. Methods: Mean CIMT based on ultrasonographic measurement of 12 sites within the common carotid artery was recorded for 2726 subjects across eight Asian countries who had two or more CVD risk factors but were not receiving lipid-lowering therapy. CVD risk factors and lipid and glucose profiles were analyzed with respect to distribution of CIMT and high-sensitivity C-reactive protein (hs-CRP) values. Results: The overall mean (SD) of mean CIMT (mean-mean CIMT) was 0.662 (0.16) mm. There was a significant variation in mean-mean CIMT across countries (P < 0.0001). Mean-mean CIMT values (mm) by age were: 0.485, 0.527, 0.614, 0.665, 0.715 and 0.797 for ≤29, 30-39, 40-49, 50-59, 60-69 and ≥70 years, respectively. Multivariate analyses confirmed a significant association between increasing mean-mean CIMT and increasing age, male gender, low high-density lipoprotein-cholesterol (HDL-C) levels and elevated fasting blood glucose levels. Analysis of log-transformed hs-CRP levels showed significant association with increasing waist circumference, low-density lipoprotein-cholesterol, body-mass index, high blood glucose levels and low HDL-C. Conclusions: Our data show normative mean-mean CIMT data for Asian subjects with two or more CVD risk factors who are not receiving lipid-lowering therapy, which may guide CVD risk-stratification of asymptomatic individuals in Asia.

Keywords
Carotid intima media thickness CIMT Atherosclerosis Cardiovascular risk factors Asia

References

1.
1. Cheung BM. The cardiovascular continuum in Asia - a new paradigm for the metabolic syndrome. J Cardiovasc Pharmacol 2005;46:125-9.
2.
2. World Health Organization. Health Situation in the South-East Asian Region 2001-2007. Availableat:http://www.searo.who.int/LinkFiles/Evidence_&_Health_Information_Health_ Situations_SEAR 2001-2007.pdf. (accessed February 2012).
3.
3. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
4.
4. Kablak-Ziembicka A, TraczW, Przewlocki T, Pieniazek P, Sokolowski A, Konieczynska M. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart 2004;90:1286- 90.
5.
5. Devine PJ, Carlson DW, Taylor AJ. Clinical value of carotid intima-media thickness testing. J Nucl Cardiol 2006;13:710-8.
6.
6. Grewal J, Anand S, Islam S, Lonn E. Prevalence and predictors of subclinical atherosclerosis among asymptomatic “low risk” individuals in a multiethnic population. Atherosclerosis 2008;197:435-42.
7.
7. O’Leary DH, Polak JF, Kronmal RA,Manolio TA, Burke GL,Wolfson RA. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health
8.
Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
9.
8. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
10.
9. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-67.
11.
10. Dijk JM, van der Graaf Y, Bots ML, Grobbee DE, Algra A. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study. Eur Heart J 2006;27:1971-8.
12.
11. Sun Y, Lin CH, Lu CJ, Yip PK, Chen RC. Carotid atherosclerosis, intima media thickness and risk factors—an analysis of 1781 asymptomatic subjects in Taiwan. Atherosclerosis 2002;164:89-94.
13.
12. Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279-84.
14.
13. D’Agostino Jr RB, Burke G, O’Leary D, et al. Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke 1996;27:1744-9.
15.
14. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol 2002;90:953-8.
16.
15. Howard G, Sharrett AR, Heiss G, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993;24:1297-304.
17.
16. Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008;21:93-111.
18.
17. Dodani S. Atherothrombosis in South Asians: implications of atherosclerotic and inflammatory markers. Open Cardiovasc Med J 2010;4:45-50.
19.
18. Youn YJ, Lee NS, Kim JY, et al. Normative values and correlates of mean common carotid intima-media thickness in the Korean rural middle-aged population: the Atherosclerosis RIsk of Rural Areas iN Korea General Population (ARIRANG) study. J Korean Med Sci 2011;26:365-71.
20.
19. Woo KS, Chook P, Raitakari OT, McQuillan B, Feng JZ, Celermajer DS.Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler ThrombVasc Biol 1999;19:2487-93.
21.
20. Watanabe H, Yamane K, Fujikawa R, Okubo M, Egusa G, Kohno N.Westernization of lifestyle markedly increases carotid intima-media wall thickness (IMT) in Japanese people. Atherosclerosis 2003;166:67- 72.
22.
21. Bots ML, Grobbee DE. Intima media thickness as a surrogate marker for generalized atherosclerosis. Cardiovasc Drugs Ther 2002;16:341-51.
23.
22. Jarauta E, Mateo-Gallego R, Bea A, Burillo E, Calmarza P, Civeira F. Carotid intima- media thickness in subjects with no cardiovascular risk factors. Rev Esp Cardiol 2010;63:97-102.
24.
23. Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke 1997;28:665-71.
25.
24. Fritz HF, Jutzy RV, Bansal R, Housten-Feenstra L. Validation of an automated computerized analyzing
26.
system for measuring common carotid artery intima-media thickness by brightness mode ultrasound. J Vasc Ultrasound 2005;29:21-6.
27.
25. Thomas GN, Chook P, Qiao M, et al. Deleterious impact of “high normal” glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol 2004;24:739- 43.
28.
26. Duprez DA, Somasundaram PE, Sigurdsson G, Hoke L, Florea N, Cohn JN. Relationship between C-reactive protein and arterial stiffness in an asymptomatic population. J Hum Hypertens 2005;19:515-9.
29.
27. Kones R. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease—a perspective. Drug Des Devel Ther 2010;4: 383-413.
30.
28. Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010;55: 1600-7.
31.
29. Crouse III JR, Craven TE, Hagaman AP, Bond MG. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation 1995;92:1141-7.

Tác giả

Byung-Hee Oh: Bệnh viện Trường Đại học quốc gia Seoul, Hàn Quốc; Rinambaan W.M. Kaligis: Trung tâm tim mạch quốc gia Harapan Kita, Jakarta, Indonesia; Yongjun Wang: Bệnh viện Thiên Tân, Bắc Kinh, Trung Quốc; Felix Eduardo R.Punzalan: Trường Đại học Y khoa Philippines, Manila, Philippines; Nijasri C. Suwanwela: Bệnh viện Chulalongkorn Memorial, Trường Đại học Chulalongkorn, Bangkok, Thái Lan; Nguyễn Lân Việt: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai; Tsong-Hai Lee: Bệnh viện Chang Gung Memorial, Trung tâm y khoa, Đài Loan; Kui-Hian Sim: Bệnh viện tim Sarawak, Đại học Sarawak, Kuching, Malaysia; Yohji Itoh: AstraZeneca, Osaka, Nhật Bản; Namrata Bahadur: AstraZeneca, Singapore; Joy Leong: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
No translate

Files

Article Views674
Document Views1
Downloads19
Section NGHIÊN CỨU LÂM SÀNG
Category TIM MẠCH DỰ PHÒNG
Pages 45-56
Copyright Holder 2014 Tạp chí Tim mạch học Việt Nam